BioEngine Ventures, part of Centerlab Pharmaceutical Corporation, focuses on children's medication and invests in various healthcare sectors like advanced medical materials, pharmaceuticals, new drug development, health products, and nutrition.
Our notable investments:
1. Adimmune, Taiwan's sole USFDA and EMA-certified influenza vaccine manufacturer, played a crucial role during the COVID-19 outbreak, delivering returns exceeding threefold within two years.
2. XAG craft, a leading agricultural UAV company in China valued at $800 million, achieved a twofold return and plans to list in Hong Kong.
3. YIELD Hydrogen Fund, backed by Beijing Tsinghua Industrial Research Institute, targets global hydrogen energy investments. Its goals include driving China's hydrogen industry by 2030 and investing in key players like SinoHytec, the first publicly listed hydrogen energy company, and Umoe, a leading hydrogen solution provider.